alendronate and calcium lactate

alendronate has been researched along with calcium lactate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Okada, S; Ozono, K; Shima, M; Yamamoto, T; Yoshikawa, H	1
Nishii, T; Shiomi, T; Sugano, N; Tamura, S; Yoshikawa, H	1

Trials

1 trial(s) available for alendronate and calcium lactate

Article	Year
Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial. Clinical rheumatology, 2013, Volume: 32, Issue:12 Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; Calcium Compounds; Collagen Type I; Collagen Type II; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Humans; Lactates; Male; Middle Aged; Osteoarthritis, Hip; Pain; Pain Measurement; Peptide Fragments; Peptides; Prospective Studies; Severity of Illness Index; Treatment Outcome	2013

Article

Year

Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial.

Clinical rheumatology, 2013, Volume: 32, Issue:12

Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; Calcium Compounds; Collagen Type I; Collagen Type II; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Humans; Lactates; Male; Middle Aged; Osteoarthritis, Hip; Pain; Pain Measurement; Peptide Fragments; Peptides; Prospective Studies; Severity of Illness Index; Treatment Outcome

2013

Other Studies

1 other study(ies) available for alendronate and calcium lactate

Article	Year
Alendronate and pharmacological doses of 1alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia. Journal of bone and mineral metabolism, 2002, Volume: 20, Issue:3 Topics: Adult; Alendronate; Bone and Bones; Calcium Compounds; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Humans; Hydroxycholecalciferols; Hypophosphatemia; Lactates; Phosphates; Radionuclide Imaging	2002

Article

Year

Alendronate and pharmacological doses of 1alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia.

Journal of bone and mineral metabolism, 2002, Volume: 20, Issue:3

Topics: Adult; Alendronate; Bone and Bones; Calcium Compounds; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Humans; Hydroxycholecalciferols; Hypophosphatemia; Lactates; Phosphates; Radionuclide Imaging

2002